President and Co-Founder, Institute for Systems Biology
Lee Hood, M.D., Ph.D., is an unparalleled pioneer in the translation of technology from R&D to industry. He is the co-founder of the Institute for Systems Biology in Seattle, and is a pioneer in systems approaches to biology and medicine.
A pillar in the biotechnology field, Dr. Hood has co-founded more than 14 companies, including Amgen, Applied Biosystems, Systemix, Darwin and Rosetta. Amgen and Applied Biosystems have a combined market capitalization of over $50B. He is also the co-founded of Integrated Diagnostics, an InterWest portfolio company. Dr. Hood's research has focused on the study of molecular immunology, biotechnology and genomics. His professional career began at Caltech, where he and his colleagues developed the DNA gene sequencer and synthesizer and the protein synthesizer and sequencer—four instruments that paved the way for the successful mapping of the human genome and led to his receiving this year's prestigious Russ Prize, awarded by the Academy of Engineering.
Dr. Hood is a member of the National Academy of Sciences, the National Academy of Engineering, and the Institute of Medicine. Of the 6,000+ scientists who belong to one or more of these academies, Dr. Hood is one of only ten scientists who belong to all three of them. He is also a member of the American Philosophical Society and a Fellow of the American Academy of Arts and Sciences. His work has been widely published and he has coauthored numerous textbooks in biochemistry, immunology, molecular biology and genetics, as well as a popular book on the human genome project, The Code of Codes. He is the recipient of numerous awards, including the Lasker Award, the Kyoto Prize and the Heinz Award in Technology, and has received 17 honorary degrees.